Literature DB >> 15931215

Treatment of severe autoimmune disease by stem-cell transplantation.

Megan Sykes1, Boris Nikolic.   

Abstract

Transplantation of haematopoietic stem cells--cells capable of self renewing and reconstituting all types of blood cell--can treat numerous lethal diseases, including leukaemias and lymphomas. It may now be applicable for the treatment of severe autoimmune diseases, such as therapy-resistant rheumatoid arthritis and multiple sclerosis. Studies in animal models show that the transfer of haematopoietic stem cells can reverse autoimmunity, and several mechanistic pathways may explain this phenomenon. The outcome of ongoing clinical trials, as well as of studies in patients and animal models, will help to determine the role that stem-cell transplantation can play in the treatment of autoimmune diseases.

Entities:  

Mesh:

Year:  2005        PMID: 15931215     DOI: 10.1038/nature03728

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; K C R Malmegrim; A F Ferreira; R Tognon; S Kashima; C E B Couri; D T Covas; J C Voltarelli; F A de Castro
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

2.  Immune-mediated myelopathy following allogeneic stem cell transplantation.

Authors:  Miwa Sakai; Kazuteru Ohashi; Keiko Ohta; Takuya Yamashita; Hideki Akiyama; Shuji Kisida; Noriko Kamata; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

Review 3.  Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.

Authors:  Falk Hiepe; Thomas Dörner; Anja E Hauser; Bimba F Hoyer; Henrik Mei; Andreas Radbruch
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

4.  Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells.

Authors:  Ulrike Baranyi; Birgit Linhart; Nina Pilat; Martina Gattringer; Jessamyn Bagley; Ferdinand Muehlbacher; John Iacomini; Rudolf Valenta; Thomas Wekerle
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

Review 5.  [Current value of stem-cell transplantation in autoimmune diseases].

Authors:  I Kötter; M Schmalzing; J Henes; W Vogel; L Kanz
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

Review 6.  T and B lymphocyte differentiation from hematopoietic stem cell.

Authors:  Anne Y Lai; Motonari Kondo
Journal:  Semin Immunol       Date:  2008-06-25       Impact factor: 11.130

7.  In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism.

Authors:  Yu-Ru Shih; Heemin Kang; Vikram Rao; Yu-Jui Chiu; Seong Keun Kwon; Shyni Varghese
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

8.  Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.

Authors:  L C M Arruda; J C C Lorenzi; A P A Sousa; D L Zanette; P V B Palma; R A Panepucci; D S Brum; A A Barreira; D T Covas; B P Simões; W A Silva; M C Oliveira; K C R Malmegrim
Journal:  Bone Marrow Transplant       Date:  2014-12-08       Impact factor: 5.483

9.  Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases.

Authors:  Dominique Farge; Myriam Labopin; Alan Tyndall; Athanasios Fassas; Gian Luigi Mancardi; Jaap Van Laar; Jian Ouyang; Tomas Kozak; John Moore; Ina Kötter; Virginie Chesnel; Alberto Marmont; Alois Gratwohl; Riccardo Saccardi
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

10.  HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen.

Authors:  Nainong Li; Dongchang Zhao; Mark Kirschbaum; Chunyan Zhang; Chia-Lei Lin; Ivan Todorov; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.